# In Vivo Glycocalyx as Predictor of Complications After Cardiac Surgery

> **NCT04643535** · — · TERMINATED · sponsor: **University Hospital, Rouen** · enrollment: 130 (actual)

## Conditions studied

- Endothelial Dysfunction
- Cardiovascular Diseases
- Surgery

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04643535
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2020-11-30
- **Primary completion:** 2024-07-03
- **Final completion:** 2025-12-30
- **Target enrollment:** 130 (ACTUAL)
- **Why stopped:** The period of authorization for effective inclusion has ended at 130 inclusions out of a theoretical 600.
- **Last updated:** 2026-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04643535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04643535, "In Vivo Glycocalyx as Predictor of Complications After Cardiac Surgery". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT04643535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*